Photosensitization of hematoporphyrin monomethyl ether enhance cellular concentrations of AS-ODNs targeting Bcr-abl gene in K562 cells and efficacy of AS-ODNs killing K562 cells

被引:0
|
作者
Xu, Chuan Shan [1 ,3 ]
Zhang, Lin [2 ]
Yu, Le Hua [1 ]
Wang, Zhi Gang [1 ]
Yang, Qing [3 ]
Zeng, Xia Bo [1 ]
机构
[1] Chongqing Univ Med Sci, Inst Ultrasound Imaging, Chongqing 400010, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Chongqing 400037, Peoples R China
[3] Third Mil Med Univ, Southwest Hosp, Chongqing 400037, Peoples R China
来源
FOURTH INTERNATIONAL CONFERENCE ON PHOTONICS AND IMAGING IN BIOLOGY AND MEDICINE, PTS 1 AND 2 | 2006年 / 6047卷
关键词
photon; hematoporphyrin monomethyl ether; photosensitization; photodynamic therapy; antisense oligonucleotides; antisense therapy; Bcr-abl gene; chronic myeloid leukemia; cell growth; cell cycle distribution; apoptosis;
D O I
10.1117/12.710943
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
This study was to investigate the effect of photosensitization of Hematoporphyrin monomethyl ether (HMME) on the intracellular uptake of antisense oligonucleotides (AS-ODNs) and cytotoxicity of AS-ODNs targeting bcr-abl gene in K562 cells. The cells were randomized into the experimental group and the controls. The cells in the experimental group were treated by photosensitization of HMME with AS-ODNs. The cells in the controls were treated by photosensitization of HMME, AS-ODNs alone, HMME treatment alone, laser radiation alone or sham radiation, respectively. Light source was from laser with red light (650 nm) delivered at a total dose of 9 J cm(-2). The intracellular uptake of AS-ODNs was measured with flow cytometry and fluorescence microscope, and the proliferation of K562 cells was investigated by colony formation and cell cycle distribution was analyzed by flow cytometry and apoptosis was measured with terminal deoxyuridine nicked-labeling (TUNEL) assay. The results showed that the cells treated by photosenstization have higher fluorescence intensity compared with the cells in the controls. At 24 h after photosensitization with AS-ODNs, a 31% increase in the proportion of cells in the G0-G1 phase relative to sham irradiation was observed and G1 arrest,occurred concurrently with a reduction in the percentage of S-phase cells and the rate of apoptosis in K562 cells significantly increased up to 8.60 +/- 0.04%. At 14(th) day, treatment of photosensitization with AS-ODNs resulted in a significant decrease in colony formation in K562 cells. Our data demonstrate that photosensitization of HMME could enhance intracellular concentrations of AS-ODNs in K562 cells and increase the efficacy of AS-ODNs killing cells. Combination of photosensitization of HMME with AS-ODNs may be of value for more effective management of cancer.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells
    Rowley, PT
    Keng, PC
    Kosciolek, BA
    LEUKEMIA RESEARCH, 1996, 20 (06) : 473 - 480
  • [23] Semi-random mutagenesis profile of BCR-ABL during imatinib resistance acquirement in K562 cells
    Dong, Yan
    Gao, Xiaotong
    Zhao, Yingxin
    Wei, Mengying
    Xu, Lingmin
    Yang, Guodong
    Liu, Li
    MOLECULAR MEDICINE REPORTS, 2017, 16 (06) : 9409 - 9414
  • [24] Evaluation of Morpholino Antisense Oligos' Role on BCR-ABL Gene Silencing in the K562 Cell Line
    Haririan, Mahmoud
    Kaviani, Saeid
    Soleimani, Masoud
    Noruzinia, Mehrdad
    Abroun, Saeid
    Ghaemi, Soraya Rasi
    Delalat, Bahman
    YAKHTEH, 2010, 12 (02): : 241 - 248
  • [25] BCR-ABL1 fusion gene acquisition of endothelial cells from K562 spent serum
    Kocana, C. C.
    Toprak, S. F.
    Sozer, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 500 - 500
  • [26] BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells
    Traina, F
    Carvalheira, JBC
    Saad, MJA
    Costa, FF
    Saad, STO
    FEBS LETTERS, 2003, 535 (1-3) : 17 - 22
  • [27] Camptothecin acts synergistically with imatinib and overcomes imatinib resistance through Bcr-Abl independence in human K562 cells
    Ju, Dong-Sik
    Kim, Mi-Ju
    Bae, Jae-Ho
    Song, Hye-Soon
    Chung, Byung-Seon
    Lee, Min-Ki
    Kang, Chi-Dug
    Lee, Hyun-Sun
    Kim, Dong-Wan
    Kim, Sun-Hee
    CANCER LETTERS, 2007, 252 (01) : 75 - 85
  • [28] Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells
    Park, Soo-Jung
    Kim, Mi-Ju
    Kim, Hak-Bong
    Sohn, Hee-Young
    Bae, Joe-Ho
    Kang, Chi-Dug
    Kim, Sun-Hee
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (11) : 1809 - 1818
  • [29] p53 mediates breakdown of the anti-apoptotic protein Bcr-Abl in K562 leukaemia cells
    DiBacco, A
    Cotter, TG
    BRITISH JOURNAL OF CANCER, 1998, 78 : 23 - 23
  • [30] Synergistic cytotoxicity effect of the combination of chitosan nanoencapsulated imatinib mesylate and quercetin in BCR-ABL positive K562 cells
    Kamyabi, Rohollah
    Jahandideh, Alireza
    Panahi, Negar
    Muhammadnejad, Samad
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2023, 26 (03) : 359 - 366